Sign In
US Tariffs: Citi Sees Minimal Impact On Indian Pharma Firms
Pharma Stocks and Trump's Proposed 35% Tariffs: Potential Impact on Sun Pharma, DRL, and Aurobindo
US tariffs: Global brokerage firm Citi sees minimal impact on Indian pharma firms
Indian Pharma To Gain Amid Higher US Tariffs
What Can Be Done To Address Growing Vaccine Scepticism?
Pharma Cos Under Govt Lens For Quality Issues
Latest News
Enhancing Cloud Security Posture through Managed Azure Services for Enterprises
Discover India’s Golden Triangle: A Complete Delhi Agra Jaipur Tour Guide
Customer Loyalty Programs for Restaurants: Driving Repeat Business and Lasting Connections
Credit Management Software: Optimizing Financial Workflows and Reducing Risk
USV launches new product for diabetes care in India
Eli Lilly launches Weight Loss Drug Mounjaro in India
Tobacco May Well Be The Future Of Pharmaceutical Production
Hyd’s Utopia Working On Obesity Vaccine
Indian Generic Drugs Meet Global Standards
Zydus to buy majority stake in Amplitude for 256.8 mn Euros
